Skip to main content

Research Repository

Advanced Search

Prevalence, Incidence, and Mortality of Raynaud’s phenomenon, Sjögren’s syndrome, and scleroderma: an umbrella review of systematic reviews

Chen, Anthony; Lax, Stephanie J; Grainge, Matthew J; Lanyon, Peter C; Pearce, Fiona A

Prevalence, Incidence, and Mortality of Raynaud’s phenomenon, Sjögren’s syndrome, and scleroderma: an umbrella review of systematic reviews Thumbnail


Authors

Anthony Chen

Peter C Lanyon



Abstract

Objectives:

To comprehensively review systematic reviews of prevalence, incidence, and mortality of Raynaud’s, Sjögren’s, and Scleroderma, and to identify any research gaps.

Methods:

An umbrella review of English language systematic reviews was undertaken using PubMed and Embase (OVID) covering the period 2000-2023 (PROSPERO CRD42023434865). The estimate and its corresponding 95% confidence interval were reported when available from each systematic review. The quality of systematic reviews was assessed using the Scottish Intercollegiate Guidelines Network (SIGN) tool. A narrative synthesis was undertaken.

Results:

17 systematic reviews were identified, of which one was for Raynaud’s, five for Sjögren’s and 11 for Scleroderma. There were some high-quality systematic reviews for Sjögren’s and mortality of Scleroderma. However, there were only low-quality systematic
reviews of prevalence and incidence of Raynaud’s and Scleroderma. Furthermore, there were no systematic reviews for the mortality of Raynaud’s. For Raynaud’s, the pooled prevalence was 4850 per 100,000; pooled annual incidence was 250 per 100,000. For Sjögren’s, prevalence was 60-70 per 100,000; annual incidence was 6.92 per 100,000 and the pooled standardised mortality ratio ranged from 1.38-1.48. For Scleroderma, pooled prevalence ranged from 17.6-23 per 100,000; annual incidence was 1.4 per 100,000; and the pooled standardised mortality ratio ranged from 2.72-3.53.

Conclusion:

The outcomes of Raynaud’s were less-well described compared to Sjögren’s and Scleroderma. There was a lack of high-quality systematic reviews for the prevalence and incidence of Raynaud’s and Scleroderma. Therefore, further studies and systematic reviews with rigorous case definitions, assessing different ethnic groups are warranted in this area.

Citation

Chen, A., Lax, S. J., Grainge, M. J., Lanyon, P. C., & Pearce, F. A. (2024). Prevalence, Incidence, and Mortality of Raynaud’s phenomenon, Sjögren’s syndrome, and scleroderma: an umbrella review of systematic reviews. Rheumatology Advances in Practice, 8(3), Article rkae086. https://doi.org/10.1093/rap/rkae086

Journal Article Type Article
Acceptance Date Jul 1, 2024
Online Publication Date Jul 27, 2024
Publication Date Jul 27, 2024
Deposit Date Jul 9, 2024
Publicly Available Date Jul 10, 2024
Journal Rheumatology Advances in Practice
Electronic ISSN 2514-1775
Publisher Oxford University Press
Peer Reviewed Peer Reviewed
Volume 8
Issue 3
Article Number rkae086
DOI https://doi.org/10.1093/rap/rkae086
Keywords Umbrella review, Prevalence, Incidence, Mortality, Raynaud’s, Sjögren’s, and Scleroderma
Public URL https://nottingham-repository.worktribe.com/output/37146850

Files





You might also like



Downloadable Citations